[

sinovac

]

China's Covid-19 vaccine sales drop as nations switch to mRNA shots

The efficacy of China’s inactivated vaccines ranges from about 50% to 80% in clinical trials. But they are less potent than mRNA vaccines and questions are mounting about their effectiveness against the highly transmissible delta variant.
A lab technician holds a vial of Chinese Sinovac's CoronaVac vaccine against coronavirus disease (Covid-19) in Constantine, Algeria, on September 29, 2021. (Ramzi Boudina / REUTERS)
A lab technician holds a vial of Chinese Sinovac's CoronaVac vaccine against coronavirus disease (Covid-19) in Constantine, Algeria, on September 29, 2021. (Ramzi Boudina / REUTERS)
Published on Sep 30, 2021 07:40 AM IST
Copy Link
Bloomberg |

Lead Sinovac scientist dies of suspected Covid as Indonesia mulls booster shot

  • The death of a leading Indonesian scientist has added questions to the efficacy of the Sinovac vaccine which has been widely used in the fourth-most populous nation.
Across Indonesia, the coronavirus pandemic is again spreading rapidly with bursting beyond capacity and oxygen supplies are running out.(AP)
Across Indonesia, the coronavirus pandemic is again spreading rapidly with bursting beyond capacity and oxygen supplies are running out.(AP)
Published on Jul 08, 2021 04:48 PM IST
Copy Link
Byhindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi

Singapore latest to cast doubt over Chinese Sinovac efficacy. Here’s why

  • Singapore has included only Pfizer and Moderna vaccines in its national vaccination program but has allowed private health clinics to administer Sinovac.
Singapore has included only Pfizer and Moderna vaccines in its national vaccination program but allowed private health clinics to administer Sinovac.
Singapore has included only Pfizer and Moderna vaccines in its national vaccination program but allowed private health clinics to administer Sinovac.
Updated on Jun 20, 2021 09:15 PM IST
Copy Link
Byhindustantimes.com | Edited by Kunal Gaurav, Hindustan Times, New Delhi

WHO expects to review Chinese Covid-19 vaccines on April 26: Official

WHO emergency use listing is a prequisite for being purchased by the COVAX vaccine-sharing facility.
Employees pick up vials containing CoronaVac, Sinovac's vaccine against Covid-19, in Sao Paulo, Brazil.(REUTERS / File)
Employees pick up vials containing CoronaVac, Sinovac's vaccine against Covid-19, in Sao Paulo, Brazil.(REUTERS / File)
Updated on Apr 09, 2021 07:48 PM IST
Copy Link
Reuters | , Geneva

Sinovac says its vaccine is safe for children as young as 3

More than 70 million shots of Sinovac’s vaccine have been given worldwide, including in China.
Early and mid-stage clinical trials with over 550 subjects showed the vaccine would induce an immune response, Gang Zeng, the medical director at Sinovac, said at a news conference. (Representative Image)(Bloomberg)
Early and mid-stage clinical trials with over 550 subjects showed the vaccine would induce an immune response, Gang Zeng, the medical director at Sinovac, said at a news conference. (Representative Image)(Bloomberg)
Published on Mar 23, 2021 01:17 PM IST
Copy Link
AP |

Hong Kong to vaccinate teachers, cab drivers despite reports of adverse events

At least two people have died and several fallen seriously ill after receiving a vaccination by China's Sinovac.
People queue up at a community vaccination centre to receive a dose of the Sinovac Biotech coronavirus disease (COVID-19) vaccine, in Hong Kong, China. (REUTERS)
People queue up at a community vaccination centre to receive a dose of the Sinovac Biotech coronavirus disease (COVID-19) vaccine, in Hong Kong, China. (REUTERS)
Updated on Mar 08, 2021 02:35 PM IST
Copy Link
Reuters | , Hong Kong

Thailand starts Covid-19 vaccination campaign with China's Sinovac vaccines

Prime Minister Prayuth Chan-ocha, 66, attended the event, although his age falls outside the range of 18 to 59 suitable to receive SinoVac's CoronaVac vaccine, so he did not get it.
Thailand's Prime Minister Prayut Chan-O-Cha (R) looks at a vial of the Coronavac Covid-19 coronavirus vaccine, developed by China's Sinovac firm, beside Yang Xin, Chargé d'Affaires of the Chinese embassy. (AFP)
Thailand's Prime Minister Prayut Chan-O-Cha (R) looks at a vial of the Coronavac Covid-19 coronavirus vaccine, developed by China's Sinovac firm, beside Yang Xin, Chargé d'Affaires of the Chinese embassy. (AFP)
Published on Feb 28, 2021 08:43 AM IST
Copy Link
Reuters | , Bangkok

Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand

Thailand’s Food and Drug Administration has approved Sinovac Biotech Ltd.’s Covid-19 vaccine for local emergency use ahead of the launch of a national inoculation program.
A health worker gets ready to collect samples during proactive testing of migrant workers at their work place, amid the spread of the coronavirus disease (COVID-19) outbreak in Samut Sakhon province in Thailand. (REUTERS)
A health worker gets ready to collect samples during proactive testing of migrant workers at their work place, amid the spread of the coronavirus disease (COVID-19) outbreak in Samut Sakhon province in Thailand. (REUTERS)
Updated on Feb 23, 2021 12:59 PM IST
Copy Link
Bloomberg |

Covid-19 vaccination: Second pan-India dry run today, Chinese vaccine found 78% effective in Brazil

Immunisation drives against Covid-19 are currently underway in several countries. Vaccines developed by Pfizer-BioNTech SE and Moderna are being most widely used.
A healthcare worker prepares a Pfizer coronavirus disease (COVID-19) vaccination in Los Angeles, California, U.S., January 7, 2021. REUTERS/Lucy Nicholson/File Photo
A healthcare worker prepares a Pfizer coronavirus disease (COVID-19) vaccination in Los Angeles, California, U.S., January 7, 2021. REUTERS/Lucy Nicholson/File Photo
Updated on Jan 08, 2021 09:26 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Thailand to get 2 million doses of China’s Sinovac Covid-19 vaccine

The country will receive the vaccine in three batches, with the first 200,000 doses arriving in February, 800,000 in March, and another 1 million in April, according to its health ministry.
Officers offload a box of Sinovac's vaccine for coronavirus disease (COVID-19) as it arrives at the cold room of Indonesia's local health department in Palembang, South Sumatra province, Indonesia, January 4, 2021 in this photo taken by Antara Foto. Antara Foto/Nova Wahyudi/ via REUTERS
Officers offload a box of Sinovac's vaccine for coronavirus disease (COVID-19) as it arrives at the cold room of Indonesia's local health department in Palembang, South Sumatra province, Indonesia, January 4, 2021 in this photo taken by Antara Foto. Antara Foto/Nova Wahyudi/ via REUTERS
Updated on Jan 04, 2021 10:34 AM IST
Copy Link
ByBloomberg | Posted by Karan Manral

Covid-19 vaccine updates: India likely to decide on first vaccine this week, South Korea seeks Moderna’s candidate

On Monday, the United States and Mexico commenced phase 3 trials of the vaccine candidate of Novovax, an American biotech firm.
A medical worker receives the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at Santa Maria hospital in Lisbon, Portugal, December 28, 2020. REUTERS/Pedro Nunes
A medical worker receives the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine at Santa Maria hospital in Lisbon, Portugal, December 28, 2020. REUTERS/Pedro Nunes
Updated on Dec 29, 2020 09:32 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

Sinovac vaccine shot’s efficacy uncertain despite Brazil, Turkey results

Sinovac is finalizing results of phase III trials carried out in Brazil, Turkey, Indonesia and Chile, according to a person familiar with the trials.
A worker inspects syringes of a vaccine for Covid-19 produced by Sinovac at its factory in Beijing.(AP)
A worker inspects syringes of a vaccine for Covid-19 produced by Sinovac at its factory in Beijing.(AP)
Published on Dec 25, 2020 03:01 PM IST
Copy Link
ByBloomberg| Posted by Mallika Soni

Brazil scientists say Sinovac vaccine CoronaVac has proven effective in late-stage trials: Report

Brazil is the first country to complete late-stage trials of CoronaVac, which is also being tested in Indonesia and Turkey.
Refrigerated containers with China's Sinovac vaccines against the coronavirus disease (COVID-19) arrive at Sao Paulo International Airport in Guarulhos, Brazil.(REUTERS)
Refrigerated containers with China's Sinovac vaccines against the coronavirus disease (COVID-19) arrive at Sao Paulo International Airport in Guarulhos, Brazil.(REUTERS)
Updated on Dec 22, 2020 01:31 PM IST
Copy Link
Sao Paolo/Rio De Janeiro | ByReuters | Posted by Shankhyaneel Sarkar

Covid-19 vaccine update: Serum Institute of India seeks emergency use approval for Covishield, Sputnik V phase 2 trials begin in Pune

On Sunday, Indonesia received 1.2 million doses of the vaccine candidate of China’s Sinovac. The first shot of Pfizer’s vaccine, meanwhile, is likely to be administered to people in the United Kingdom on Tuesday.
Boxes containing the vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine are seen inside a cold room at the Serum Institute of India, in Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas
Boxes containing the vials of AstraZeneca's COVISHIELD, coronavirus disease (COVID-19) vaccine are seen inside a cold room at the Serum Institute of India, in Pune, India, 30 November 2020. Picture taken November 30, 2020. REUTERS/Francis Mascarenhas
Updated on Dec 07, 2020 08:17 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Karan Manral

China’s Sinovac secures $500 million in funding for Covid-19 vaccine development

In a statement on its website, the company said it expects to be able to manufacture 300 million vaccine doses annually, and that it aims to complete construction of a second production facility by the end of 2020 to increase annual Covid-19 vaccine production capacity to 600 million doses.
Sinovac said the investor is Sino Biopharmaceutical Ltd.(Reuters)
Sinovac said the investor is Sino Biopharmaceutical Ltd.(Reuters)
Updated on Dec 07, 2020 06:23 AM IST
Copy Link
Shanghai | ByReuters| Posted by Susmita Pakrasi

1.2 million doses of China-made Covid-19 vaccine arrives in Indonesia

President Joko Widodo said in a televised address that another 1.8 million doses of the vaccine are expected to arrive in early January.
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China.(REUTERS)
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China.(REUTERS)
Published on Dec 06, 2020 09:39 PM IST
Copy Link
Associated Press | ByAssociated Press | Posted by Shankhyaneel Sarkar

Brazil’s Sau Paulo could roll out China’s Covid-19 vaccine without approval

Sau Paulo governor Joao Doria in an interview on Thursday said Sinovac could be rolled out without approval from the national health regulator, in comments described by health experts as ‘empty threat.’
FILE PHOTO: Brazil's Sao Paulo state governor, Joao Doria, and director of Instituto Butantan, Dimas Tadeu Covas, hold boxes of the China's Sinovac vaccine against the coronavirus disease (COVID-19) as a cargo plane containing the vaccines arrives at Sao Paulo International Airport in Guarulhos, Brazil November 19, 2020. REUTERS/Amanda Perobelli/File Photo(REUTERS)
FILE PHOTO: Brazil's Sao Paulo state governor, Joao Doria, and director of Instituto Butantan, Dimas Tadeu Covas, hold boxes of the China's Sinovac vaccine against the coronavirus disease (COVID-19) as a cargo plane containing the vaccines arrives at Sao Paulo International Airport in Guarulhos, Brazil November 19, 2020. REUTERS/Amanda Perobelli/File Photo(REUTERS)
Updated on Nov 27, 2020 07:58 AM IST
Copy Link
Sau Paulo | ByReuters | Posted by Karan Manral

China vaccine trial halted in Brazil after serious adverse event

Serious adverse events that occur in drug trials include death, immediate risk of death, long term or serious incapacitation, and hospitalization.
China has already started administering its vaccines, including Coronavac, to hundreds of thousands of people under an expansive emergency use approval.(AP File Photo)
China has already started administering its vaccines, including Coronavac, to hundreds of thousands of people under an expansive emergency use approval.(AP File Photo)
Updated on Nov 10, 2020 01:38 PM IST
Copy Link
ByBloomberg | Posted by Srivatsan K C

China’s Sinovac vaccine is safe, Brazil institute says

The result is only preliminary and researchers will keep monitoring the participants in the on-going trial, Covas said. It’s the first set of results of Sinovac’s Phase 3 global trials, which are also being conducted in Turkey and Indonesia.
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech.(REUTERS)
A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech.(REUTERS)
Updated on Oct 20, 2020 09:38 AM IST
Copy Link
Beijing/Sao Paolo | ByReuters | Posted by Shankhyaneel Sarkar

China rapidly expands use of experimental COVID-19 vaccines

The city of Jiaxing, south of Shanghai, is offering a vaccine under development by Sinovac, it said in an announcement Thursday.
More than 168,000 people signed up to receive the vaccine via an online survey and more than 91,000 are being considered. In Picture - Vaccine for COVID-19 produced by Sinovac is displayed during a media tour of its factory in Beijing.(AP)
More than 168,000 people signed up to receive the vaccine via an online survey and more than 91,000 are being considered. In Picture - Vaccine for COVID-19 produced by Sinovac is displayed during a media tour of its factory in Beijing.(AP)
Updated on Oct 16, 2020 04:53 PM IST
Copy Link
Taipei | ByAssociated Press | Posted by Srivatsan K C

China’s Jiaxin to sell Sinovac’s Covid-19 vaccine for $60 in cases of emergency

Hundreds of thousands of people have been given experimental vaccines in late-stage trials as part of an emergency inoculation programme launched in July.
People work in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China.(REUTERS)
People work in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China.(REUTERS)
Updated on Oct 16, 2020 02:16 PM IST
Copy Link
Beijing | ByReuters | Posted by Shankhyaneel Sarkar

China’s Sinovac to test Covid-19 vaccine candidate in kids, teens. Know more

According to a registration record published on Wednesday, 552 healthy participants aged between three and 17 will take two doses of US-listed Sinovac’s CoronaVac or a placebo in a combined Phase 1 and Phase 2 trial estimated to begin on September 28 in the northern Chinese province of Hebei.
A staff member places a coronavirus vaccine candidate from Sinovac Biotech Ltd at its booth for display during the 2020 China International Fair for Trade in Services (CIFTIS) in Beijing in this file photo.(Reuters Photo)
A staff member places a coronavirus vaccine candidate from Sinovac Biotech Ltd at its booth for display during the 2020 China International Fair for Trade in Services (CIFTIS) in Beijing in this file photo.(Reuters Photo)
Updated on Sep 18, 2020 11:58 AM IST
Copy Link
Hindustan Times, New Delhi | Byhindustantimes.com | Edited by Meenakshi Ray

China’s Sinovac coronavirus vaccine candidate appears safe, slightly weaker in elderly

Health officials have been concerned about whether experimental vaccines could safely protect the elderly, whose immune systems usually react less robustly to vaccines, against the virus that has led to nearly 890,000 deaths worldwide.
A sign for Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS) in China.(Reuters)
A sign for Sinovac Biotech Ltd is seen at the 2020 China International Fair for Trade in Services (CIFTIS) in China.(Reuters)
Updated on Sep 08, 2020 07:25 AM IST
Copy Link
Beijing, China | ByReuters | Posted by Shivani Kumar

Indonesia kicks off third phase of Sinovac’s Covid-19 vaccine testing

Indonesia began the third phase of a Covid-19 vaccine trial made by China’s Sinovac Biotech Ltd. with a target to begin commercial production in six months.
Once the vaccine clears the trials successfully, state-owned PT Bio Farma may begin production from January, President Joko Widodo said.(File photo for representation)
Once the vaccine clears the trials successfully, state-owned PT Bio Farma may begin production from January, President Joko Widodo said.(File photo for representation)
Updated on Aug 11, 2020 03:48 PM IST
Copy Link
ByBloomberg | Posted by Niyati Singh

Chinese vaccine maker inks deal in Brazil for final testing

Beijing has mobilized its health authorities, drug regulators and research institutes to work around the clock with local companies to come up with the world’s first effective vaccine for Covid-19.
A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia.(REUTERS)
A scientist dilutes samples during the research and development of a vaccine against the coronavirus disease (COVID-19) at a laboratory of BIOCAD biotechnology company in Saint Petersburg, Russia.(REUTERS)
Updated on Jun 12, 2020 05:20 PM IST
Copy Link
Bloomberg | ByBloomberg
SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Friday, December 03, 2021